ANALYST RECOMMENDATIONS : AstraZeneca, Netflix, Nordstrom, Phillips 66, Zscaler...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• AstraZeneca: Credit Suisse downgrades from Outperform to Neutral targeting GBp 11,000.
• BT Group: HSBC upgrades from hold to buy targeting GBp 185.
• Devon: J.P. Morgan downgrades to neutral from overweight. PT up 15% to $83.
• Electronic Arts : Atlantic Equities downgrades to neutral from overweight. PT up 2.4% to $130.
• EOG Resources: JPMorgan raises to overweight from neutral, price target to $156 from $152.
• GSK: Credit Suisse upgrades from Underperform to Neutral with a target of GBp 1430.
• Hyatt: Berenberg raised the recommendation to buy from hold. PT up 13% to $105.
• Kohl's: Jefferies downgrades to hold from buy. PT up 1.1% to $29.
• Masimo: Wolfe Research upgrades to outperform from peerperform. PT up 9.5% to $165.
• Netflix: Evercore ISI upgrades to outperform from inline. PT up 34% to $300.
• Nordstrom: Jefferies upgrades to buy from hold. PT up 33% to $24.
• Okta: Jefferies starts at Buy With $90 Price Target.
• Phillips 66: Wolfe Research downgrades to peer perform from outperform.
• Quanta Services: Goldman Sachs downgrades to neutral from buy. PT up 5.4% to $150.
• Tate & Lyle: Citigroup upgrades from neutral to buy targeting GBp 850.
• Zscaler: Jefferies starts at Hold With $200 Price Target